Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis
出版年份 2017 全文链接
标题
Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 27, Pages 5004
出版商
Baishideng Publishing Group Inc.
发表日期
2017-07-21
DOI
10.3748/wjg.v23.i27.5004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
- (2016) Simin Zhang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
- (2015) Chote Luangchosiri et al. BMC Complementary and Alternative Medicine
- Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
- (2015) Gianpaolo Sorrentino et al. Drugs in research & development
- Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease
- (2015) Ludovico Abenavoli et al. Expert Review of Gastroenterology & Hepatology
- Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
- (2014) Paola Stiuso et al. Oxidative Medicine and Cellular Longevity
- Chemopreventive and Anti-Cancer Efficacy of Silibinin Against Growth and Progression of Lung Cancer
- (2013) Samiha Mateen et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial
- (2012) Mostafa Yakoot et al. BMC GASTROENTEROLOGY
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study
- (2012) Ali Akbar Hajiaghamohammadi et al. Hepatitis Monthly
- Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
- (2012) Michael W. Fried JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
- (2012) Federico Salamone et al. Translational Research
- Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease
- (2011) Ludovico Abenavoli HEPATOLOGY RESEARCH
- Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial
- (2010) N. D. Freedman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage
- (2009) E. Shaker et al. FOOD AND CHEMICAL TOXICOLOGY
- A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
- (2009) Samer S. El-Kamary et al. PHYTOMEDICINE
- Multitargeted therapy of cancer by silymarin
- (2008) Kumaraguruparan Ramasamy et al. CANCER LETTERS
- The Pharmacokinetics of Silymarin Is Altered in Patients with Hepatitis C Virus and Nonalcoholic Fatty Liver Disease and Correlates with Plasma Caspase-3/7 Activity
- (2008) S. J. Schrieber et al. DRUG METABOLISM AND DISPOSITION
- Silybin Treatment is Associated With Reduction in Serum Ferritin in Patients With Chronic Hepatitis C
- (2008) Julie M. Bares et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started